Germ-Line ATM Gene Alterations Are Associated with Susceptibility to Sporadic T-Cell Acute Lymphoblastic Leukemia in Children

Genes Chromosomes and Cancer

Volumn 39, Issue 2, 2004, Pages 161-166

  Liberzon, Ella ^a,b   Avigad, Smadar ^a,b,c   Stark, Batia ^b,c   Zilberstein, Julia ^a,b   Freedman, Laurence ^d   Gorfine, Malka ^d   Gavriel, Herzel ^e   Cohen, Ian J ^b,c   Goshen, Yacov ^b,c   Yaniv, Isaac ^b,c   Zaizov, Rina ^a,b,c  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^d BAR ILAN UNIVERSITY   (Israel)

^e HAEMEK MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; DNA; PROTEIN P53; RNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; AGE; ARTICLE; ATAXIA TELANGIECTASIA; ATM GENE; CANCER SUSCEPTIBILITY; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; DISEASE COURSE; ETHNOLOGY; FEMALE; GENE; GENE MUTATION; GENETIC SUSCEPTIBILITY; GERM LINE; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; T CELL LEUKEMIA;

ATAXIA TELANGIECTASIA; CELL CYCLE PROTEINS; CHILD; CHILD, PRESCHOOL; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HETEROZYGOTE DETECTION; HUMANS; LEUKEMIA, T-CELL, ACUTE; MALE; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 9144255469     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10306     Document Type: Article

References (40)

1. Athma P, Rappaport R, Swift M. 1996. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 92:130-134.
2. Barel D, Avigad S, Michovitz S, Cohen IJ, Zaizov R. 1997. Infrequent p53 mutation and mdm-2 amplification in childhood brain tumors. Int J Ped Hem/Oncol 4:91-100.
3. Batel D, Avigad S, Mor S, Fogel M, Cohen IJ, Zaizov R. 1998. A novel germ-line mutation in the noncoding region of the p53 gene in a Li-Fraumeni family. Cancer Genet Cytogenet 103:1-6.
4. Becker-Catania SG, Chen G, Hwang MJ, Wang Z, Sun X, Sanal O, Bernatowska-Matuszkiewicz E, Chessa L, Lee EY-HP, Gatti RA. 2000. Ataxia-telangiectasia: phenotypejgenotype studies of ATM protein expression, mutations, and radiosensitivity. Mol Genet Metab 70:122-133.
5. Blau O, Avigad S, Stark B, Kodman Y, Luria D, Cohen IJ, Zaizov R. 1997. Exon 5 mutations in the p53 gene in relapsed childhood acute lymphoblastic leukemia. Leuk Res 21:721-729.
6. Blau O, Avigad S, Stark B, Benyaminy H, Luria D, Kodman Y, Cohen IJ, Goshen Y, Yaniv I, Zaizov R. 2000. p53 mutation in intron 6 as a diagnostic marker for high risk childhood T-lineage acute lymphoblastic leukemia. Int J Pediatric Hem/Oncol 6:361-367.
7. Broeks A, Urbanus JHM, Floore AN, Dahler EC, Klijn JGM, Rutgers EJTh, Devilee P, Russell NS, van Leeuwen FE, van't Veer LJ. 2000. ATM-heterozygous germline mutations contribute to breast cancer-susceptibility. Am J Hum Genet 66:494-500.
8. Byrd PJ, McConville CM, Cooper P, Parkhill J, Stankovic T, McGuire GM, Thick JA, Taylor AMR. 1996. Mutations revealed by sequencing the 5′ half of the gene for ataxia telangiectasia. Hum Mol Genet 5:145-149.
9. Camacho E, Hernandez L, Hernandez S, Tort F, Bellosillo B, Bea S, Bosch F, Montserrat E, Cardesa A, Fernandez PL, Campo E. 2002. ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances. Blood 99:238-244.
10. Easton DF. 1994. Cancer risks in A-T heterozygotes. Int J Radiat Biol 66:S177-S182.
11. Fang NY, Greiner TC, Weisenburger DD, Chan WC, Vose JM, Smith LM, Armitage JO, Mayer RA, Pike BL, Collins FS, Hacia JG. 2003. Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma. Proc Natl Acad Sci USA 29:5372-5377.
12. Gatti RA, Tward A, Concannon P. 1999. Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations. Mol Genet Metab 68:419-423.
13. Gilad S, Bar-Shira A, Harnik R, Shkedy D, Ziv Y, Khosravi R, Brown K, Vanagaite L, Xu G, Frydman M, Lavin MF, Hill D, Tagle DA, Shiloh Y. 1996a. Ataxia-telangiectasia: founder effect among North African Jews. Hum Mol Genet 5:2033-2037.
14. Gilad S, Khosravi R, Shkedy D, Uziel T, Ziv Y, Savitsky K, Rotman G, Smith S, Chessa L, Jorgensen TJ, Harnik R, Frydman M, Sanal O, Portnoi S, Goldwicz Z, Jaspers NGJ, Gatti RA, Lenoir G, Lavin MF, Tatsumi K, Wegner RD, Shiloh Y, Bar-Shira A. 1996b. Predominance of null mutations in ataxia-telangiectasia. Hum Mol Genet 5:433-439.
15. Gilad S, Khosravi R, Harnik, R, Ziv Y, Shkedy D, Galanty Y, Frydman M, Levi J, Sanal O, Chessa L, Smeets D, Shiloh Y, Bar-Shira A. 1998. Identification of ATM mutations using extended RT-PCR and restriction endonuclease fingerprinting, and elucidation of the repertoire of A-T mutations in Israel. Hum Mut 11:69-75.
16. Gronbaek K, Worm J, Ralfkiaer E, Ahrenkiel V, Hokland P, Guldberg P. 2002. ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma. Blood 100:1430-1437.
17. Kukita Y, Tahira T, Sommer SS, Hayashi K. 1997. SSCP analysis of long DNA fragments in low pH gel. Hum Mutat 10:400-407.
18. Lavin MF, Concannon P, Gatti RA. 1999. Eighth International Workshop on Ataxia-Telangiectasia (ATW8). Cancer Res 59:3845-3849.
19. Luo L, Lu F-M, Hart S, Foroni L, Rabbani H, Hammarstrom L, Webster ADB, Vorechovsky I. 1998. Ataxia-telangiectasia and T-cell leukemias: no evidence for somatic ATM mutation in sporadic T-ALL or for hypermethylation of the ATM-NPAT/E14 bidirectional promoter in T-PLL. Cancer Res 58:2293-2297.
20. Maillet P, Bonnefoi H, Vaudan-Vutskits G, Pajk B, Cufer T, Foulkes WD, Chappuis PO, Sappino A-P. 2002. Constitutional alterations of the ATM gene in early onset sporadic breast cancer. J Med Genet 39:751-753.
21. Morrell D, Cromartie E, Swift M. 1986. Mortality and cancer incidence in 263 patients with ataxia telangiectasia. J Natl Cancer Inst 77:89-92.
22. Morrell D, Chase CL, Swift M. 1990. Cancers in 44 families with ataxia-telangiectasia. Cancer Genet Cytogenet 50:119-123.
23. Offit K, Gilad S, Paglin S, Kolachana P, Roisman LC, Nafa K, Yeugelewitz V, Gonzales M, Robson M, McDermott D, Pierce HH, Kauff ND, Einat P, Jhanwar S, Satagopan JM, Oddoux C, Ellis N, Skaliter R, Yahalom J. 2002. Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancers. Clin Cancer Res 8:3813-3819.
24. Oguchi K, Takagi M, Tsuchida R, Taya Y, Ito E, Isoyama K, Ishii E, Zannini L, Delia D, Mizutani S. 2003. Missense mutations and defective function of ATM in a childhood acute leukemia patient with MLL gene rearrangement. Blood 101:3622-3627.
25. Olsen JH, Hahnemann JM, Borresen-Dale A-L, Brondum-Nielsen K, Hammarstrom L, Kleinerman R, Kaariainen H, Lonnqvist T, Sankila R, Seersholm N, Tretli S, Yuen J, Boice JD Jr., Tucker M. 2001. Cancer in patients with ataxia-telangiectasia and in their relatives in the Nordic countries. J Natl Cancer Inst 93:121-127.
26. Pause FG, Wacker P, Maillet P, Betts D, Sappino AP. 2003. ATM gene alterations in childhood acute lymphoblastic leukemias. Hum Mutat 21:554.
27. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Sankhavaram R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NGJ, Taylor AMR, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y. 1995a. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749-1753.
28. Savitsky K, Sfez S, Tagle DA, Ziv Y, Sartiel A, Collins FS, Shiloh Y, Rotman G. 1995b. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet 4:2025-2032.
29. Scott SP, Bendix R, Chen P, Clark R, Dork T, Lavin MF. 2002. Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer. Proc Natl Acad Sci USA 22:925-930.
30. Shiloh Y. ATM and related protein kinases: Safeguarding genome integrity. 2003. Nat Rev Cancer 3:155-168.
31. Sommer SS, Buzin CH, Jung M, Zheng J, Liu Q, Jeong SJ, Moulds J, Nguyen VQ, Feng J, Bennett WP, Dritschilo A. 2002. Elevated frequency of ATM gene missense mutations in breast cancer relative to ethnically matched controls, Cancer Genet Cytogenet 134:25-32.
32. Stankovic T, Kidd AMJ, Sutcliffe A, McGuire GM, Robinson P, Weber P, Bedenham T, Bradwell AR, Easton DF, Lennox GG, Haites N, Byrd PJ, Taylor AMR. 1998. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet 62:334-345.
33. Stankovic T, Steart GS, Byrd P, Fegan C, Moss PAH, Taylor AMR. 2002. ATM mutations in sporadic lymphoid tumours. Leuk Lymphoma 43:1563-1571.
34. Stark B, Sharon R, Rechavi G, Attias D, Ballin A, Cividalli G, Burstein Y, Sthoeger D, Abramov A, Zaizov R. 2000. Effective preventive central nervous system therapy with extended triple intrathecal therapy and the modified ALL-BFM 86 chemotherapy program in an enlarged non-high risk group of children and adolescents with non-B-cell acute lymphoblastic leukemia: The Israel National study report. Cancer 88:205-216.
35. Swift M, Morrell D, Cromartie E, Chamberlin AR, Skolnick MH, Bishop DT. 1986. The incidence and gene frequency of ataxia telangiectasia in the United States. Am J Hum Genet 39:573-583.
36. Swift M, Morrell D, Massey RB, Chase CL. 1991. Incidence of cancer in 161 families affected by ataxia telangiectasia. N Engl J Med 325:1831-1836.
37. Takeuchi S, Koike M, Park S, Seriu T, Bartram CR, Taub HE, Williamson IK, Grewal J, Taguchi H, Koeffler HP. 1998. The ATM gene and susceptibility to childhood T-cell acute lymphoblastic leukaemia. Br J Haematol 103:536-538.
38. Taylor AM. 1992. Ataxia telangiectasia genes and predisposition to leukaemia, lymphoma and breast cancer. Br J Cancer 66:5-9.
39. Taylor AMR, Metcalfe JA, Thick J, Mak Y-F. 1996. Leukemia and lymphoma in ataxia telangiectasia. Blood 87:423-438.
40. Thorstenson YR, Shen P, Tusher VG, Wayne TL, Davis RW, Chu G, Oefner PJ. 2001. Global analysis of ATM polymorphism reveals significant functional constraint. Am J Hum Genet 69:396-412.